Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

3.9 (CAD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2023202220212020201920182017
Operating Activities:
Net Income -37.392-23.917-23.37-4.011-7.241-14.833-4.998
Depreciation & Amortization 0.210.1930.1120.1170.2020.1260.085
Deferred Income Tax 0-0.3051.2040.011-0.0290.2910
Stock Based Compensation 1.8711.4344.2150.2290.5452.9160.163
Change In Working Capital 7.2232.073-0.2111.560.4821.099-0.599
Accounts Receivables -0.140.310.1910.7280.135-0.209-0.34
Inventory -0.578-1.32400000
Accounts Payables 0.5781.32400000
Other Working Capital 7.3631.763-0.4020.8320.3471.307-0.259
Other Non Cash Items 0.1711.163.4091.690.8692.0810.051
Operating Cash Flow -27.916-18.776-14.642-0.404-5.171-8.32-5.298
Investing Activities:
Investments In Property Plant And Equipment -0.097-0.308-0.4320-0.009-0.142-0.315
Acquisitions Net 0000.081000
Purchases Of Investments 0-0-90000
Sales Maturities Of Investments 09.00900000
Other Investing Activites -0.0020-5.018-0.057-1.88600
Investing Cash Flow -0.0998.701-14.450.025-1.895-0.142-0.315
Financing Activities:
Debt Repayment -0.144-0.09712.169-0.5265.6642.6740.463
Common Stock Issued 15.88710.63729.673001.6537.193
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 5.2722.9848.073-0.1011.7352.6211.811
Financing Cash Flow 21.01413.52349.915-0.6277.3995.2959.467
Other Information:
Effect Of Forex Changes On Cash 0.8210.397-0.082-0000
Net Change In Cash 0.7683.84420.742-1.0060.333-3.1673.854
Cash At End Of Period 25.50424.73620.8920.151.1560.8233.99